About this Presentation
This presentation explains why reproductive carrier screening should be discussed with all couples planning pregnancy. Testing during pregnancy is possible, but less optimal. There are different options, primarily either three-gene test or expanded carrier screening. The clinical utility of a carrier screening test doesn’t just depend on the number of genes tested.
About the Expert
Dr James Harraway
Dr James Harraway is a genetic pathologist, who supervises genetic testing at Sullivan Nicolaides Pathology and Mater Pathology. He trained in New Zealand, and was the first genetic pathologist from that country. He has interests in somatic mutation testing, cytogenetics and non-invasive prenatal testing. Dr Harraway is a member of the Genetics Advisory committee of the RCPA, and supervises trainees in addition to his clinical laboratory work.
